Swiss-based firms spend tens of millions lobbying Brussels
Thelikes of tobacco company Philip Morris invest millions in trying to influence EU lawmakers.
Keystone / Laurent Gillieron
Companies based in Switzerland spent between €44 million and €60 million (CHF48-66 million) lobbying European Union bodies, according to the monitoring organisation Lobbywatch.
This content was published on
1 minute
swissinfo.ch/mga
The chemicals industry invested the most money (up to €8.4 million) in presenting their arguments to top EU officials on proposed regulations, legislation and other matters. The Swiss-based Dow Europe spent up to €2.75 million while pharmaceutical company Novartis weighed in with upwards of €2.5 million and crop protection firm Syngenta spent some €1.75 million.
The pharma industry came second in the list of sector-based spendersExternal link, followed by banks and the environmental industry. Tobacco firms collectively invested some €2.4 million in Brussels last year.
Lobbywatch collated its data from the EU’s transparency registerExternal link, which contains information on 275 companies and organisations with their headquarters in Switzerland. Companies must publish their lobbying expenditure in bandwidths of spending. Switzerland has rejected such transparency to monitor lobbying.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Big companies get ready for a contentious political season
This content was published on
Our analysis of what the biggest global companies in Switzerland are up to. This week: companies mixed up in politics and foreign aid.
This content was published on
Parliamentarians are increasingly, and more aggressively, representing particular interests. It’s a cultural change in the legislature.
Switzerland ‘more interested in tobacco firms than citizen health’
This content was published on
“Switzerland seems to be more interested in the well-being of the tobacco companies than in the health of its citizens,” noted the authors of the annual surveyExternal link, the European Network for Smoking Prevention.External link In 2013, Switzerland occupied 13th spot in the annual survey, according to the Working Group for Tobacco Prevention SwitzerlandExternal link.…
Health policy battle exposes interest groups’ political reach
This content was published on
The debate leading up to the national vote on public health insurance has reawakened controversy on the role of lobbies in Swiss healthcare policy.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.